Kairos Pharma, LTD.

NYSE:KAPA

Pharmaceutical Preparations·LOS ANGELES, CA

Kairos is an ancient Greek word meaning 'the exact or critical time'. In modern Greek, kairos also means 'weather' or 'time'.

CEO

Yu John S

CFO

Samuelson Doug

Financials

7 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-K/A	FY 2024	12/31/24	7/28/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K/A	FY 2024	12/31/24	4/29/25	→
10-K	FY 2024	12/31/24	4/15/25	→
↓

News (8-K)

24 shown

Filed	Type	Description
3/2/26	Agreement	Entry into a Material Definitive Agreement	→
2/26/26	Other	Other Events	→
10/15/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/7/25	Agreement	Entry into a Material Definitive Agreement	→
9/18/25	Other	Other Events	→
9/11/25	Other	Other Events	→
↓

Prospectuses & Registrations

17 shown

Filed	Form	Description
1/13/26	S-3	S-3	→
8/19/25	424B3	424B3	→
4/25/25	424B3	424B3	→
4/22/25	S-1	S-1	→
2/5/25	424B3	424B3	→
1/29/25	S-1	S-1	→
↓

Filing History(106 filings)

TypeDateAccessionPeriodSize

8-K

Mar 2, 2026

0001493152-26-0084358-K

Mar 2, 2026

282.8 KB

8-K

Feb 26, 2026

0001493152-26-0081168-K

Feb 26, 2026

225.1 KB

EFFECT

Jan 23, 2026

9999999995-26-000284

—

1.7 KB

CORRESP

Jan 21, 2026

0001493152-26-002996

—

12.1 KB

UPLOAD

Jan 15, 2026

0000000000-26-000555

—

39.1 KB

S-3

Jan 13, 2026

0001493152-26-001909S-3

—

1.0 MB

Dec 30, 2025

0001493152-25-0296014

Oct 8, 2025

4.9 KB

Dec 23, 2025

0001493152-25-0288954

Sep 16, 2025

6.9 KB

Nov 26, 2025

0001493152-25-0252244

Oct 8, 2025

4.9 KB

Nov 26, 2025

0001493152-25-0252054

Sep 16, 2025

6.9 KB

Nov 26, 2025

0001493152-25-0252034

Oct 8, 2025

4.8 KB

Nov 26, 2025

0001493152-25-0251984

Oct 8, 2025

5.0 KB

Nov 26, 2025

0001493152-25-0251974

Oct 8, 2025

5.6 KB

10-Q

Nov 14, 2025

0001493152-25-02327610-Q

Sep 30, 2025

16.1 MB

8-K

Oct 15, 2025

0001493152-25-0181458-K

Oct 8, 2025

250.4 KB

8-K

Oct 7, 2025

0001493152-25-0172088-K

Oct 1, 2025

268.8 KB

8-K

Sep 18, 2025

0001493152-25-0139758-K

Sep 18, 2025

5.9 MB

8-K

Sep 11, 2025

0001493152-25-0130408-K

Sep 11, 2025

227.9 KB

8-K

Sep 3, 2025

0001641172-25-0263168-K

Sep 3, 2025

230.3 KB

424B3

Aug 19, 2025

0001641172-25-024858424B3

—

2.6 MB

SCHEDULE 13G/A

Aug 14, 2025

0001172661-25-003587

—

10.3 KB

10-Q

Aug 12, 2025

0001641172-25-02316710-Q

Jun 30, 2025

4.4 MB

10-K/A

Jul 28, 2025

0001641172-25-02113410-K/A

Dec 31, 2024

690.1 KB

8-K

Jul 15, 2025

0001641172-25-0196458-K

Jul 15, 2025

223.8 KB

8-K

Jun 12, 2025

0001641172-25-0149058-K

Jun 10, 2025

287.6 KB

25 filings shown

Filed	Form	Description
5/16/25	DEFR14A	DEFR14A	→
5/1/25	DEF 14A	DEF 14A	→
2/10/25	DEF 14C	DEF 14C	→
1/29/25	PRE 14C	PRE 14C	→

Kairos Pharma, LTD.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(106 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/30/25	4	4	→
12/23/25	4	4	→
11/26/25	4	4	→
11/26/25	4	4	→
11/26/25	4	4	→
11/26/25	4	4	→
↓

Filed	Form	Description
1/23/26	EFFECT	EFFECT	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	SCHEDULE 13G	SCHEDULE 13G	→
5/6/25	PRER14A	PRER14A	→
4/24/25	EFFECT	EFFECT	→
2/4/25	EFFECT	EFFECT	→
↓